Carboxy-directed asymmetric hydrogenation of 1,1-diarylethenes and 1,1-dialkylethenes.
Shou‐Fei Zhu,Song Song,Yan-Bo Yu,Qi‐Lin Zhou
DOI: https://doi.org/10.1002/anie.201208606
2013-01-28
Angewandte Chemie
Abstract:Owing to high atom economy, chemoselectivity, and stereoselectivity, the transition-metal-catalyzed asymmetric hydrogenation of C=C bonds has become one of the most reliable methods for the preparation of optically active compounds both in academia and in industry. In the asymmetric hydrogenation of a double bond, chiral induction arises from catalyst differentiation of the prochiral faces of the bond. The Re and Si faces are much easier to differentiate if the substituents are very different in size, as is the case for 1-aryl-1-alkyl ethenes, and high enantioselectivities can be achieved. In sharp contrast, differentiation of the Reand Sifaces is difficult if the substituents are very similar in size, as is the case for 1,1-diarylethenes and 1,1-dialkylethenes, and enantioselectivities with such substrates are low. In the hydrogenation of 1,1-diarylethenes, high enantioselectivities have been achieved only when one of the aryl groups has an ortho-substituent. In the asymmetric hydrogenation of 1,1-dialkylethenes, the highest enantioselectivity reported to date is only 41% ee. Therefore, it is highly desirable to develop a new strategy to realize the asymmetric hydrogenation of 1,1-diarylethenes and 1,1-dialkylethenes, because the products of this reaction, diaryl and dialkylethanes, are very useful in the synthesis of biologically active compounds. Recently, we developed highly efficient chiral iridium catalysts bearing spiro phosphine–oxazoline ligands for the asymmetric hydrogenation of a,b-unsaturated and b,gunsaturated carboxylic acids. The carboxy group of the unsaturated acids anchors the catalyst and directs the hydrogenation of the double bond. This finding encouraged us to study the carboxy group as a directing group for the asymmetric hydrogenation of 1,1-diarylethenes and 1,1-dialkylethenes. Herein, we report the highly enantioselective iridium-catalyzed hydrogenation of 1,1-diarylethenes 1 and 1,1-dialkylethenes 4 directed by a carboxy group. When used in combination with a convenient decarboxylation, the hydrogenation of 1 provides an effective method for the construction of chiral diarylethanes 3, which are core structures for many biologically active compounds, such as sleep-inducing H1-antihistamines, [9] the antiparasitic agent demiditraz, and anticancer agents. The hydrogenation of 4 provides an efficient method for preparing chiral g-methyl fatty acids 5, which are important intermediates for natural products such as the pheromone of rhinoceros beetles (Scheme 1). Substrates 1 and 4 were easily prepared by Wittig olefination of the corresponding ketones (for details, see the Supporting Information). First, we chose 2-(1-phenylvinyl)benzoic acid (1a) as a model substrate to evaluate various chiral iridium/spiro phosphine–oxazoline catalysts 6 for the carboxy-directed asymmetric hydrogenation (Scheme 1). Catalyst (Sa)-6a, which has phenyl groups on the phosphorous atom and no substituent on the oxazoline ring, showed 100% conversion and afforded 2a with 99 % ee within 5 h (Table 1, entry 1). The substituents on the aryl groups of the phosphorous atom affected the reaction rate and enantioselectivity only slightly (entries 2 and 3 vs. entry 1). The use of catalyst (Sa)-6b, which has 3,5-dimethylphenyl groups on the phosphorous atom, decreased the reaction time from 5 to 4 h, but the enantioselectivity remained high (99 % ee ; entry 2). However, catalyst (Sa)-6c, which has bulkier 3,5-di-tertbutylphenyl groups on the phosphorous atom, required Scheme 1. Carboxy-directed asymmetric hydrogenation of 1,1-diarylethenes and 1,1-dialkylethenes catalyzed by chiral iridium/spiro phosphine–oxazoline complexes. BArF = tetrakis[3,5-bis(trifluoromethyl)phenyl]borate.
Chemistry,Medicine